A study using targeted next-generation sequencing revealed that 12 of 18 (67%) EEM specimens had gene alterations (TP53, PIK3CA, EGFR, MYCN) associated with ESCC [9]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.